by Jordana Choucair | Nov 4, 2021 | Life Sciences
U.K. regulators authorized Merck & Co.’s COVID-19 antiviral pill molnupiravir, making it first in the world to clear the treatment. The FDA is still reviewing the drug, though the federal government made an advance purchase of 1.7 million courses of the...
by Mindy Klowden | Nov 3, 2021 | Blog, Latest News, Mental Health & Addiction
Amid the COVID-19 pandemic, state and federal lawmakers established emergency, regulatory flexibilities – including eliminating requirements that patients have an established, pre-existing relationship with a provider, reimbursing telehealth at the same rates as...
by Jordana Choucair | Nov 3, 2021 | Providers
The CMS released three final rules pertaining to provider payments: The annual Outpatient Prospective Payment System rule increases payment rates for hospital-owned outpatient and ambulatory surgery centers by 2 percent each and finalizes steeper penalties for certain...
by Jordana Choucair | Nov 3, 2021 | Payers
Humana released its third-quarter earnings report today, posting $1.5 billion in Q3 profits. The report also shows that Humana expects its Medicare Advantage (MA) individual membership to grow 11 percent compared to the previous year. However, the insurer also cut its...
by Jordana Choucair | Nov 3, 2021 | Health IT
FAIR Health’s Monthly Telehealth Regional Tracker shows that telehealth use among individuals with private health insurance increased by almost 13 percent from July to August. The top five reasons for telehealth visits in August were mental health conditions...
Recent Comments